Nucleic Acid Silencing Agent-protein Conjugates and Use Thereof for Treating Hcv-related Disorders

A method of using a complex or a molecule comprising a targeting moiety to deliver a second molecule effectively to HCV or to a cell being infected or having the potential to be infected by HCV, resulting in the prevention, immunization, inhibition or cure of HCV infection, or other beneficial effects related to HCV infection

Patents:
WO 2,009,143,345

Inventor(s): BABCOCK GREGORY J [US]; AMBROSINO DONNA M [US]; FINBERG ROBERT W [US]; ZAMORE PHILLIP D [US]; BROERING TERESA [US]

Type of Offer: Sale



« More Biotech Patents

---